ArticleJournal of pharmacy & bioallied sciences2025
Observational Study on the Effectiveness of Ventilator-Assisted Preoxygenation (VAPOX) Over Bag Valve Mask (BVM) Ventilation During Rapid Sequence Intubation in Patients with Acute Respiratory Distress.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the effectiveness of Ventilator-Assisted Preoxygenation (VAPOX) compared with Bag Valve Mask (BVM) ventilation during Rapid Sequence Intubation (RSI) in patients presenting with acute respiratory distress. Materials and Methods: This observational study enrolled 60 critically ill patients requiring emergency intubation. Participants aged 40-90 years were consecutively allocated to receive preoxygenation by either VAPOX ( Results: Patients in the VAPOX group reached 95% SpO Conclusion: VAPOX is superior to BVM for preoxygenation during RSI in critically ill patients, demonstrating faster oxygenation, better maintenance of oxygen saturation, and significantly improved PaO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.